- Home
- PROF vs INBX Comparison
PROF vs INBX Comparison
Compare PROF & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- INBX
- Stock Information
- Founded
- PROF N/A
- INBX 2010
- Country
- PROF Canada
- INBX United States
- Employees
- PROF N/A
- INBX N/A
- Industry
- PROF Medical/Dental Instruments
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- INBX Health Care
- Exchange
- PROF Nasdaq
- INBX Nasdaq
- Market Cap
- PROF 201.2M
- INBX 190.2M
- IPO Year
- PROF N/A
- INBX 2020
- Fundamental
- Price
- PROF $7.48
- INBX $12.56
- Analyst Decision
- PROF Strong Buy
- INBX Hold
- Analyst Count
- PROF 2
- INBX 1
- Target Price
- PROF $11.40
- INBX N/A
- AVG Volume (30 Days)
- PROF 102.1K
- INBX 88.8K
- Earning Date
- PROF 03-06-2025
- INBX 11-14-2024
- Dividend Yield
- PROF N/A
- INBX 6.77%
- EPS Growth
- PROF N/A
- INBX N/A
- EPS
- PROF N/A
- INBX 119.38
- Revenue
- PROF $8,984,000.00
- INBX $1,568,000.00
- Revenue This Year
- PROF $56.56
- INBX N/A
- Revenue Next Year
- PROF $151.33
- INBX N/A
- P/E Ratio
- PROF N/A
- INBX $0.11
- Revenue Growth
- PROF 39.35
- INBX 19.24
- 52 Week Low
- PROF $5.63
- INBX $10.80
- 52 Week High
- PROF $11.42
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- PROF 65.75
- INBX 42.38
- Support Level
- PROF $5.63
- INBX $12.08
- Resistance Level
- PROF $6.36
- INBX $13.60
- Average True Range (ATR)
- PROF 0.36
- INBX 0.76
- MACD
- PROF 0.18
- INBX 0.05
- Stochastic Oscillator
- PROF 87.26
- INBX 20.87
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.